SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

PASQUINI, Silvia

PASQUINI, Silvia  

Dipartimento di Scienze chimiche, farmaceutiche ed agrarie  

Mostra records
Risultati 1 - 20 di 39 (tempo di esecuzione: 0.024 secondi).
Titolo Data di pubblicazione Autore(i) File
2-Amino-5-arylethynyl-thiophen-3-yl-(phenyl)methanones as A1 Adenosine Receptor Positive Allosteric Modulators 2023 Oliva, Paola; Suresh, R Rama; Pasquini, Silvia; Salmaso, Veronica; Will, Edward J; Tosh, Dilip K;... Gao, Zhan-Guo; Liu, Naili; Gavrilova, Oksana; Vincenzi, Fabrizio; Varani, Katia; Jacobson, Kenneth A file con accesso da definire
4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives 2022 Catarzi, D.; Varano, F.; Vigiani, E.; Calenda, S.; Melani, F.; Varani, K.; Vincenzi, F.; Pasquini..., S.; Mennini, N.; Nerli, G.; Dal Ben, D.; Volpini, R.; Colotta, V.
A1 Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic? 2020 Vincenzi, F.; Pasquini, S.; Battistello, E.; Merighi, S.; Gessi, S.; Borea, P. A.; Varani, K.
A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's Disease 2021 Gessi, Stefania; Poloni, Tino Emanuele; Negro, Giulia; Varani, Katia; Pasquini, Silvia; Vincenzi,... Fabrizio; Borea, Pier Andrea; Merighi, Stefania
A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity? 2022 Merighi, Stefania; Nigro, Manuela; Travagli, Alessia; Pasquini, Silvia; Borea, Pier Andrea; Varan...i, Katia; Vincenzi, Fabrizio; Gessi, Stefania
A3 Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma 2021 Vincenzi, F.; Rotondo, J. C.; Pasquini, S.; Di Virgilio, F.; Varani, K.; Tognon, M.
Adenosine and inflammation: Here, there and everywhere 2021 Pasquini, S.; Contri, C.; Borea, P. A.; Vincenzi, F.; Varani, K.
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 2017 Varani, Katia; Vincenzi, Fabrizio; Ravani, Annalisa; Pasquini, Silvia; Merighi, Stefania; Gessi, ...Stefania; Setti, Stefania; Cadossi, Matteo; Borea, Pier Andrea; Cadossi, Ruggero file con accesso da definire
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets 2022 Pasquini, S.; Contri, C.; Merighi, S.; Gessi, S.; Borea, P. A.; Varani, K.; Vincenzi, F.
Adenosinergic System Involvement in Ischemic Stroke Patients' Lymphocytes 2020 Pasquini, S.; Vincenzi, F.; Casetta, I.; Laudisi, M.; Merighi, S.; Gessi, S.; Borea, P. A.; Varan...i, K.
Amino-3, 5-dicyanopyridines targeting the adenosine receptors ranging from pan ligands to combined A1/A2B partial agonists 2019 Catarzi, D.; Varano, F.; Varani, K.; Vincenzi, F.; Pasquini, S.; Dal Ben, D.; Volpini, R.; Colott...a, V.
An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer's Disease Treatment? 2021 Merighi, Stefania; Poloni, Tino Emanuele; Pelloni, Lucia; Pasquini, Silvia; Varani, Katia; Vincen...zi, Fabrizio; Borea, Pier Andrea; Gessi, Stefania
Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors 2023 Gianferrara, Teresa; Pavan, Matteo; Bassani, Davide; Vincenzi, Fabrizio; Pasquini, Silvia; Bolcat...o, Giovanni; Varani, Katia; Spalluto, Giampiero; Federico, Stephanie; Moro, Stefano
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence 2024 Bedini, Annalida; Elisi, Gian Marco; Fanini, Fabiola; Retini, Michele; Scalvini, Laura; Pasquini,... Silvia; Contri, Chiara; Varani, Katia; Spadoni, Gilberto; Mor, Marco; Vincenzi, Fabrizio; Rivara, Silvia file con accesso da definire
Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target? 2023 Merighi, Stefania; Travagli, Alessia; Nigro, Manuela; Pasquini, Silvia; Cappello, Martina; Contri..., Chiara; Varani, Katia; Vincenzi, Fabrizio; Borea, Pier Andrea; Gessi, Stefania
Design, Synthesis, and Pharmacological Characterization of Indol-3-ylacetamides, Indol-3-yloxoacetamides, and Indol-3-ylcarboxamides: Potent and Selective CB2 Cannabinoid Receptor Inverse Agonists 2012 Pasquini, S; Mugnaini, C; Ligresti, A; Tafi, A; Brogi, S; Falciani, C; Pedani, V; Pesco, N; Guida..., F; Luongo, L; Varani, Katia; Borea, Pa; Maione, S; Di Marzo, V; Corelli, F. file con accesso da definire
Development of novel pyridazinone-based adenosine receptor ligands 2018 Catarzi, Daniela; Varano, Flavia; Falsini, Matteo; Varani, Katia; Vincenzi, Fabrizio; Pasquini, S...ilvia; Dal Ben, Diego; Colotta, Vittoria
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions 2023 Papa, Alessandro; Pasquini, Silvia; Galvani, Francesca; Cammarota, Mariarosaria; Contri, Chiara; ...Carullo, Gabriele; Gemma, Sandra; Ramunno, Anna; Lamponi, Stefania; Gorelli, Beatrice; Saponara, Simona; Varani, Katia; Mor, Marco; Campiani, Giuseppe; Boscia, Francesca; Vincenzi, Fabrizio; Lodola, Alessio; Butini, Stefania
Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A1and A2A adenosine receptor antagonists/inverse agonists 2018 Varano, Flavia; Catarzi, Daniela; Falsini, Matteo; Vincenzi, Fabrizio; Pasquini, Silvia; Varani, ...Katia; Colotta, Vittoria
Modifications on the amino-3,5-dicyanopyridine core to obtain multifaceted adenosine receptor ligands with antineuropathic activity 2019 Betti, M.; Catarzi, D.; Varano, F.; Falsini, M.; Varani, K.; Vincenzi, F.; Pasquini, S.; Di Cesar...e Mannelli, L.; Ghelardini, C.; Lucarini, E.; Dal Ben, D.; Spinaci, A.; Bartolucci, G.; Menicatti, M.; Colotta, V.